Genesee Capital Advisors, LLC Buys First Trust NASDAQ-100 Technology Sector Index Fd, The Energy Select Sector SPDR Fund, CSX Corp, Sells TG Therapeutics Inc, Walmart Inc, Calix Inc

• New Purchases: QTEC, XLE, CSX, CCL, IAT, IEZ, CAI, IWO, HD, FMHI, DIS, DE, T, FMB, BK, XXII,
• Added Positions: FXL, TDOC, SCHB, ARKK, SMH, SPTL, FTSM, SPYD, BNDX, ZM, VCIT, CCXI, EW, AMZN, V, ICE, HRL, MSFT, BND, FB, MA, GTY, ADSK, TTD, IBM, IYC, TSLA, FIXD, ADBE, XOM, LMBS, CORP, ABBV,
• Reduced Positions: CALX, SFIX, CYRX, BLDP, AXGN, AAPL, NXST, QCOM, MTUM, HON, RIO, BGS, SOXX, QQQ, IWN, STAA, AVGO, ITB, BLK, IYW, ABT, TDIV, DRE, MCD, CMI, TLT, SCHZ,
• Sold Out: TGTX, WMT, FV, IGV, IHI, AZN, KEY,

For the details of Genesee Capital Advisors, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/genesee+capital+advisors%2C+llc/current-portfolio/portfolio

1. First Trust Technology AlphaDEX Fund (FXL) - 129,114 shares, 8.77% of the total portfolio. Shares added by 14.32%
2. Schwab U.S. Broad Market ETF (SCHB) - 128,456 shares, 7.43% of the total portfolio. Shares added by 12.22%
3. First Trust Enhanced Short Maturity ETF (FTSM) - 144,186 shares, 5.17% of the total portfolio. Shares added by 11.93%
4. VanEck Vectors Semiconductor ETF (SMH) - 31,835 shares, 4.64% of the total portfolio. Shares added by 14.62%
5. Apple Inc (AAPL) - 54,148 shares, 3.96% of the total portfolio. Shares reduced by 6.13%

Genesee Capital Advisors, LLC initiated holding in First Trust NASDAQ-100 Technology Sector Index Fd. The purchase prices were between $131.91 and $155.37, with an estimated average price of $143.78. The stock is now traded at around $152.540000. The impact to a portfolio due to this purchase was 3.95%. The holding were 45,787 shares as of 2021-03-31.

Genesee Capital Advisors, LLC initiated holding in The Energy Select Sector SPDR Fund. The purchase prices were between $37.56 and $53.01, with an estimated average price of $45.72. The stock is now traded at around $48.530000. The impact to a portfolio due to this purchase was 1.68%. The holding were 57,219 shares as of 2021-03-31.

Genesee Capital Advisors, LLC initiated holding in CSX Corp. The purchase prices were between $83.89 and $97.66, with an estimated average price of $91.55. The stock is now traded at around $98.765000. The impact to a portfolio due to this purchase was 1.25%. The holding were 21,711 shares as of 2021-03-31.

Genesee Capital Advisors, LLC initiated holding in Carnival Corp. The purchase prices were between $18.67 and $29.79, with an estimated average price of $23.54. The stock is now traded at around $27.070000. The impact to a portfolio due to this purchase was 0.54%. The holding were 34,186 shares as of 2021-03-31.

Genesee Capital Advisors, LLC initiated holding in iShares U.S. Regional Banks ETF. The purchase prices were between $44.92 and $59.08, with an estimated average price of $52.76. The stock is now traded at around $57.730200. The impact to a portfolio due to this purchase was 0.51%. The holding were 15,009 shares as of 2021-03-31.

Genesee Capital Advisors, LLC initiated holding in iShares U.S. Oil Equipment & Services ETF. The purchase prices were between $11.31 and $15.81, with an estimated average price of $13.37. The stock is now traded at around $12.900000. The impact to a portfolio due to this purchase was 0.5%. The holding were 61,775 shares as of 2021-03-31.

Genesee Capital Advisors, LLC added to a holding in Teladoc Health Inc by 779.92%. The purchase prices were between $171.3 and $294.54, with an estimated average price of $232.94. The stock is now traded at around $191.740000. The impact to a portfolio due to this purchase was 1.06%. The holding were 11,043 shares as of 2021-03-31.

Genesee Capital Advisors, LLC added to a holding in ARK Innovation ETF by 24.73%. The purchase prices were between $110.26 and $156.58, with an estimated average price of $135.31. The stock is now traded at around $124.570000. The impact to a portfolio due to this purchase was 0.61%. The holding were 42,753 shares as of 2021-03-31.

Genesee Capital Advisors, LLC added to a holding in SPDR Portfolio Long Term Treasury ETF by 24.38%. The purchase prices were between $38.44 and $44.88, with an estimated average price of $41.46. The stock is now traded at around $39.945000. The impact to a portfolio due to this purchase was 0.57%. The holding were 125,145 shares as of 2021-03-31.

Genesee Capital Advisors, LLC added to a holding in Zoom Video Communications Inc by 44.07%. The purchase prices were between $308.39 and $444.51, with an estimated average price of $369.11. The stock is now traded at around $331.075000. The impact to a portfolio due to this purchase was 0.32%. The holding were 5,538 shares as of 2021-03-31.

Genesee Capital Advisors, LLC added to a holding in ChemoCentryx Inc by 29.51%. The purchase prices were between $49.53 and $68.4, with an estimated average price of $60.19. The stock is now traded at around $46.920000. The impact to a portfolio due to this purchase was 0.26%. The holding were 36,492 shares as of 2021-03-31.

Genesee Capital Advisors, LLC added to a holding in The Trade Desk Inc by 41.22%. The purchase prices were between $612.58 and $903.35, with an estimated average price of $774.27. The stock is now traded at around $719.745000. The impact to a portfolio due to this purchase was 0.05%. The holding were 418 shares as of 2021-03-31.

Genesee Capital Advisors, LLC sold out a holding in TG Therapeutics Inc. The sale prices were between $41.61 and $54.3, with an estimated average price of $48.04.

Genesee Capital Advisors, LLC sold out a holding in Walmart Inc. The sale prices were between $127.53 and $148.97, with an estimated average price of $139.05.

Genesee Capital Advisors, LLC sold out a holding in First Trust Dorsey Wright Focus 5 ETF. The sale prices were between $39.83 and $45.14, with an estimated average price of $43.19.

Genesee Capital Advisors, LLC sold out a holding in iShares Expanded Tech-Software Sector ETF. The sale prices were between $326.82 and $385.88, with an estimated average price of $354.45.

Genesee Capital Advisors, LLC sold out a holding in iShares U.S. Medical Devices ETF. The sale prices were between $317.79 and $350.67, with an estimated average price of $332.71.

Genesee Capital Advisors, LLC sold out a holding in AstraZeneca PLC. The sale prices were between $47.16 and $54.44, with an estimated average price of $50.29.